Protagonist Therapeutics

Protagonist Therapeutics: Proprietary peptide technology platform to develop oral targeted therapy-based drugs and injectables for rare diseases. PTG-300 injectable hepcidin mimetic Ph 2 trials ongoing in polycythemia vera and hereditary hemochromatosis; positive updated Ph 2 results in PV presented at ASH 2020. PN-943 oral GI-restricted alpha-4-beta-7 antagonist Ph 2 in ulcerative colitis study sites activated; PTG-200, partnered w/ Janssen, oral GI-restricted IL-23R antagonist Ph 2 Crohn’s disease study ongoing.
Based in...
US - Pacific
Clinical Stage
Phase l or ll
Disease Space
Anti-inflammatory, Autoimmune, Gastrointestinal, Rare Disease
Public, USA
Market Cap
500MM - 1B
Therapeutic Modalities
Platform Technology
521 Cottonwood Drive
Suite 100
Milpitas, CA 95035
United States

Company Participants at Protagonist Therapeutics PTG-300 Opportunity Update Webinar

  • Dinesh V Patel, PhD, President & CEO

Top 10 Holders of Protagonist Therapeutics, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Fidelity Management & Research Co. LLC 19.03 5,179,770 115.82 13F 9/30/20
RTW Investments LP 12.52 3,408,961 76.22 13F 9/30/20
Farallon Capital Management LLC 10.10 2,750,000 61.49 13F 9/30/20
Adage Capital Partners GP LLC 9.26 2,520,600 56.36 13F 9/30/20
Johnson & Johnson Innovation JJDC, Inc. 9.00 2,449,183 54.76 13F 9/30/20
BVF, Inc. 8.72 2,372,288 53.04 13F 9/30/20
Consonance Capital Management LP 8.71 2,369,709 52.99 13F 9/30/20
Adage Capital Management LP 5.23 2,200,000 49.19 Stakes 5/13/20
The Vanguard Group, Inc. 7.07 1,925,441 43.05 Funds 12/31/20
Baker Bros. Advisors LP 5.86 1,596,198 35.69 13F 9/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.